SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-041793
Filing Date
2018-06-22
Accepted
2018-06-22 16:02:37
Documents
8
Period of Report
2018-06-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-15671_18k.htm 8-K 64867
2 EX-10.1 a18-15671_1ex10d1.htm EX-10.1 155670
3 EX-10.2 a18-15671_1ex10d2.htm EX-10.2 56701
4 EX-10.3 a18-15671_1ex10d3.htm EX-10.3 52289
5 EX-10.4 a18-15671_1ex10d4.htm EX-10.4 34314
6 EX-10.5 a18-15671_1ex10d5.htm EX-10.5 47593
7 EX-10.6 a18-15671_1ex10d6.htm EX-10.6 31000
8 EX-10.7 a18-15671_1ex10d7.htm EX-10.7 65627
  Complete submission text file 0001104659-18-041793.txt   509297
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 18914548
SIC: 2834 Pharmaceutical Preparations